Ginkgo Bioworks Holdings (DNA) Total Current Liabilities (2020 - 2025)
Ginkgo Bioworks Holdings filings provide 6 years of Total Current Liabilities readings, the most recent being $96.0 million for Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 10.53% to $96.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $96.0 million, a 10.53% decrease, with the full-year FY2025 number at $96.0 million, down 10.53% from a year prior.
- Total Current Liabilities hit $96.0 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $115.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $191.7 million in Q1 2023 to a low of $1.4 million in Q1 2021.
- Median Total Current Liabilities over the past 5 years was $129.8 million (2021), compared with a mean of $124.6 million.
- Biggest five-year swings in Total Current Liabilities: soared 11100.25% in 2022 and later crashed 41.79% in 2025.
- Ginkgo Bioworks Holdings' Total Current Liabilities stood at $134.8 million in 2021, then rose by 28.35% to $173.0 million in 2022, then dropped by 5.26% to $163.9 million in 2023, then tumbled by 34.54% to $107.3 million in 2024, then fell by 10.53% to $96.0 million in 2025.
- The last three reported values for Total Current Liabilities were $96.0 million (Q4 2025), $115.3 million (Q3 2025), and $96.7 million (Q2 2025) per Business Quant data.